ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC82.61

C82.61

Billable

Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C82.61 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, lymph nodes of head, face, and neck.

Key Diagnostic Point:

Cutaneous follicle center lymphoma (CFCL) is a type of non-Hodgkin lymphoma that primarily affects the skin and is characterized by the proliferation of follicle center (germinal center) B-cells. When CFCL involves the lymph nodes of the head, face, and neck, it indicates a more advanced stage of the disease, often associated with systemic symptoms. Patients may present with localized lymphadenopathy, which can be painless, and may also exhibit skin lesions that resemble other dermatological conditions. The disease can manifest with B-symptoms, including fever, night sweats, and unexplained weight loss, which are indicative of systemic involvement. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy of affected lymph nodes or skin lesions. Treatment protocols may include localized radiation therapy, chemotherapy, or immunotherapy, depending on the stage and severity of the disease. The prognosis varies based on the extent of lymph node involvement and the presence of B-symptoms, necessitating careful staging and monitoring.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from other types of lymphomas
  • Need for accurate staging based on clinical presentation
  • Documentation of B-symptoms and their impact on treatment
  • Variability in treatment protocols based on patient response

Audit Risk Factors

  • Inadequate documentation of B-symptoms
  • Failure to document staging accurately
  • Misclassification of skin lesions
  • Inconsistent treatment documentation

Specialty Focus

Medical Specialties

Hematology/Oncology

Documentation Requirements

Comprehensive clinical notes detailing symptoms, staging, and treatment plans.

Common Clinical Scenarios

Diagnosis and management of lymphomas, treatment planning, and follow-up care.

Billing Considerations

Ensure all B-symptoms are documented and correlate with treatment decisions.

Dermatology

Documentation Requirements

Detailed descriptions of skin lesions and their characteristics.

Common Clinical Scenarios

Evaluation of skin lesions that may be indicative of lymphoma.

Billing Considerations

Differentiating CFCL from other dermatological conditions is crucial for accurate coding.

Coding Guidelines

Inclusion Criteria

Use C82.61 When
  • Follow the official ICD
  • CM coding guidelines for neoplasms, ensuring accurate documentation of the site and type of lymphoma
  • Include staging information and any associated symptoms

Exclusion Criteria

Do NOT use C82.61 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

88305CPT Code

Pathology examination of lymph node biopsy

Clinical Scenario

Used when a biopsy is performed to confirm CFCL diagnosis.

Documentation Requirements

Pathology report must be included in the patient's medical record.

Specialty Considerations

Ensure the pathology report clearly indicates the type of lymphoma.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of lymphomas, improving the accuracy of data collection and reimbursement processes. C82.61 provides a clear distinction for cutaneous follicle center lymphoma, enhancing clinical understanding and treatment planning.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of lymphomas, improving the accuracy of data collection and reimbursement processes. C82.61 provides a clear distinction for cutaneous follicle center lymphoma, enhancing clinical understanding and treatment planning.

Reimbursement & Billing Impact

reimbursement processes. C82.61 provides a clear distinction for cutaneous follicle center lymphoma, enhancing clinical understanding and treatment planning.

Resources

Clinical References

  • •
    National Comprehensive Cancer Network (NCCN) Guidelines

Coding & Billing References

  • •
    National Comprehensive Cancer Network (NCCN) Guidelines

Frequently Asked Questions

What are the common symptoms of cutaneous follicle center lymphoma?

Common symptoms include painless lymphadenopathy, skin lesions, fever, night sweats, and unexplained weight loss.